As/IN Georgia-Pacific/NNP 's/POS bid/NN for/IN Great/NNP Northern/NNP Nekoosa/NNP has/VBZ shown/VBN 0/-NONE- *?*/-NONE- ,/, uninvited/JJ takeovers/NNS are/VBP still/RB alive/JJ despite/IN premature/JJ reports/NNS of/IN their/PRP$ demise/NN ./.
Therefore/RB ,/, the/DT debate/NN about/IN poison/NN pills/NNS will/MD continue/VB *-1/-NONE- to/TO rage/VB in/IN the/DT boardrooms/NNS of/IN corporations/NNS and/CC the/DT halls/NNS of/IN academia/NN ./.
Although/IN poison/NN pills/NNS come/VBP in/IN different/JJ colors/NNS and/CC shapes/NNS ,/, they/PRP usually/RB give/VBP current/JJ shareholders/NNS the/DT right/NN */-NONE- to/TO buy/VB more/JJR stock/NN of/IN their/PRP$ corporation/NN at/IN a/DT large/JJ discount/NN if/IN certain/JJ events/NNS occur/VBP --/: typically/RB ,/, if/IN a/DT hostile/JJ bidder/NN acquires/VBZ more/JJR than/IN a/DT specified/JJ percentage/NN of/IN the/DT corporation/NN 's/POS stock/NN ./.
However/RB ,/, these/DT discount/NN purchase/NN rights/NNS may/MD generally/RB be/VB redeemed/VBN *-170/-NONE- at/IN a/DT nominal/JJ cost/NN by/IN the/DT corporation/NN 's/POS directors/NNS if/IN they/PRP approve/VBP of/IN a/DT bidder/NN ./.
Supporters/NNS of/IN poison/NN pills/NNS argue/VBP that/DT their/PRP$ adoption/NN forces/VBZ bidders/NNS to/TO negotiate/VB with/IN a/DT corporation/NN 's/POS directors/NNS ,/, who/WP *T*-185/-NONE- are/VBP thereby/RB put/VBN *-1/-NONE- in/IN a/DT better/JJR position/NN 0/-NONE- */-NONE- to/TO pursue/VB the/DT long-term/JJ interests/NNS of/IN the/DT corporation/NN *T*-2/-NONE- ./.
Recent/JJ studies/NNS by/IN Georgeson/NNP &/CC Co./NNP conclude/VBP that/IN corporations/NNS with/IN poison/NN pills/NNS have/VBP experienced/VBN greater/JJR stock-price/JJ appreciation/NN than/IN corporations/NNS without/IN poison/NN pills/NNS during/IN the/DT past/JJ few/JJ years/NNS ./.
Critics/NNS of/IN poison/NN pills/NNS argue/VBP that/IN they/PRP harm/VBP shareholders/NNS by/IN *-1/-NONE- letting/VBG corporate/JJ management/NN defeat/VB takeover/NN bids/NNS at/IN premium/JJ prices/NNS and/CC by/IN *-1/-NONE- deterring/VBG premium/JJ bids/NNS from/IN *-2/-NONE- ever/RB being/VBG made/VBN *-171/-NONE- to/TO shareholders/NNS ./.
These/DT critics/NNS are/VBP backed/VBN *-172/-NONE- by/IN several/JJ academic/JJ studies/NNS showing/VBG that/IN the/DT adoption/NN of/IN poison/NN pills/NNS reduces/VBZ shareholder/NN values/NNS not/RB merely/RB in/IN the/DT short/JJ run/NN ,/, but/CC also/RB over/IN longer/JJR periods/NNS ./.
Institutional/JJ investors/NNS that/WDT *T*-186/-NONE- must/MD evaluate/VB poison/NN pills/NNS on/IN a/DT regular/JJ basis/NN are/VBP interested/JJ less/RBR *ICH*-1/-NONE- in/IN this/DT general/JJ debate/NN than/IN in/IN the/DT answers/NNS to/TO specific/JJ questions/NNS about/IN the/DT corporation/NN issuing/VBG the/DT pill/NN ./.
Does/VBZ this/DT corporation/NN have/VB a/DT high-quality/JJ management/NN team/NN with/IN a/DT good/JJ track/NN record/NN ?/.
Does/VBZ this/DT team/NN have/VB a/DT viable/JJ strategy/NN for/IN */-NONE- improving/VBG shareholder/NN values/NNS ,/, and/CC does/VBZ this/DT strategy/NN require/VB implementation/NN over/IN an/DT extended/JJ period/NN ?/.
Will/MD the/DT adoption/NN of/IN this/DT particular/JJ form/NN of/IN a/DT poison/NN pill/NN significantly/RB improve/VB the/DT chances/NNS for/IN management/NN to/TO carry/VB out/RP this/DT strategy/NN ?/.
If/IN the/DT answers/NNS to/TO these/DT questions/NNS are/VBP affirmative/JJ ,/, then/RB institutional/JJ investors/NNS are/VBP likely/JJ *-1/-NONE- to/TO be/VB favorably/RB disposed/JJ toward/IN a/DT specific/JJ poison/NN pill/NN ./.
However/RB ,/, the/DT problem/NN is/VBZ that/DT once/RB most/JJS poison/JJ pills/NNS are/VBP adopted/VBN *-173/-NONE- ,/, they/PRP survive/VBP forever/RB ./.
Although/IN the/DT current/JJ management/NN team/NN may/MD be/VB outstanding/JJ ,/, who/WP will/MD *T*-187/-NONE- be/VB the/DT CEO/NNP in/IN 10/CD years/NNS ?/.
Although/IN the/DT five-year/JJ strategy/NN may/MD be/VB excellent/JJ ,/, what/WP will/MD *T*-188/-NONE- be/VB the/DT strategy/NN in/IN 25/CD years/NNS ?/.
The/DT solution/NN to/TO this/DT problem/NN is/VBZ a/DT time-limited/JJ poison/NN pill/NN ./.
The/DT limit/NN could/MD range/VB from/IN three/CD years/NNS to/TO seven/CD years/NNS ,/, depending/VBG on/IN the/DT composition/NN of/IN the/DT management/NN team/NN and/CC the/DT nature/NN of/IN its/PRP$ strategic/JJ plan/NN ./.
At/IN the/DT end/NN of/IN this/DT period/NN ,/, the/DT poison/NN pill/NN would/MD be/VB eliminated/VBN *-174/-NONE- automatically/RB ,/, unless/IN a/DT new/JJ poison/NN pill/NN were/VBD approved/VBN *-175/-NONE- by/IN the/DT then-current/JJ shareholders/NNS ,/, who/WP *T*-189/-NONE- would/MD have/VB an/DT opportunity/NN */-NONE- to/TO evaluate/VB the/DT corporation/NN 's/POS strategy/NN and/CC management/NN team/NN at/IN that/DT time/NN ./.
One/CD rare/JJ example/NN of/IN a/DT time-limited/JJ poison/NN pill/NN is/VBZ the/DT shareholder/NN rights/NNS plan/NN adopted/VBN */-NONE- by/IN Pennzoil/NNP last/JJ year/NN after/IN it/PRP received/VBD a/DT huge/JJ litigation/NN settlement/NN from/IN Texaco/NNP ./.
Pennzoil/NNP 's/POS poison/NN pill/NN covers/VBZ five/CD years/NNS in/IN order/NN */-NONE- to/TO give/VB current/JJ management/NN enough/JJ time/NN 0/-NONE- */-NONE- to/TO put/VB these/DT proceeds/NNS to/TO work/VB in/IN a/DT prudent/JJ manner/NN *T*-1/-NONE- ./.
Another/DT interesting/JJ example/NN is/VBZ the/DT poison/NN pill/NN adopted/VBN */-NONE- recently/RB by/IN Pittsburgh-based/JJ National/NNP Intergroup/NNP Inc./NNP ,/, a/DT diversified/JJ holding/VBG company/NN ./.
The/DT State/NNP of/IN Wisconsin/NNP Investment/NNP Board/NNP ,/, which/WDT *T*-190/-NONE- owned/VBD about/IN 7/CD %/NN of/IN the/DT company/NN 's/POS voting/NN stock/NN ,/, worked/VBD with/IN management/NN *-1/-NONE- to/TO devise/VB a/DT time-limited/JJ poison/NN pill/NN ./.
This/DT pill/NN automatically/RB expires/VBZ after/IN three/CD years/NNS unless/IN *-1/-NONE- continued/VBN *-2/-NONE- by/IN a/DT vote/NN of/IN the/DT shareholders/NNS ./.
The/DT attitude/NN of/IN the/DT Wisconsin/NNP Investment/NNP Board/NNP reflects/VBZ a/DT growing/VBG receptivity/NN to/TO time-limited/JJ poison/NN pills/NNS on/IN the/DT part/NN of/IN institutional/JJ investors/NNS ,/, as/IN */-NONE- shown/VBN *-1/-NONE- by/IN the/DT discussions/NNS at/IN recent/JJ meetings/NNS of/IN the/DT Council/NNP of/IN Institutional/NNP Investors/NNPS and/CC my/PRP$ informal/JJ survey/NN of/IN several/JJ retirement/NN plans/NNS with/IN large/JJ stock/NN positions/NNS ./.
More/RBR widespread/JJ time/NN limits/NNS on/IN poison/NN pills/NNS would/MD allow/VB shareholders/NNS to/TO evaluate/VB a/DT specific/JJ poison/NN pill/NN within/IN the/DT context/NN of/IN a/DT specific/JJ management/NN team/NN 's/POS strategy/NN ./.
Such/JJ concrete/JJ analysis/NN is/VBZ likely/JJ *-1/-NONE- to/TO lead/VB to/TO more/RBR fruitful/JJ dialogue/NN between/IN management/NN and/CC shareholders/NNS than/IN the/DT abstract/JJ debate/NN about/IN poison/NN pills/NNS ./.
Mr./NNP Pozen/NNP is/VBZ the/DT general/JJ counsel/NN and/CC a/DT managing/VBG director/NN of/IN Fidelity/NNP Investments/NNPS in/IN Boston/NNP ./.

